All data are based on the daily closing price as of December 24, 2024
g
Grape King Bio
1707.TW
4.59 USD
-0.05
-1.08%
Overview
Last close
4.59 usd
Market cap
679.47M usd
52 week high
5.88 usd
52 week low
4.09 usd
Target price
5.37 usd
Valuation
P/E
15.2284
Forward P/E
17.3611
Price/Sales
2.0467
Price/Book Value
2.2397
Enterprise Value
588.17M usd
EV/Revenue
1.7164
EV/EBITDA
5.9837
Key financials
Revenue TTM
332.02M usd
Gross Profit TTM
259.39M usd
EBITDA TTM
87.07M usd
Earnings per Share
0.3 usd
Dividend
N/A usd
Total assets
15.05B usd
Net debt
N/A usd
About
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distribution; and Original Design Manufacturer/Original Equipment Manufacturer segments. The company offers Chinese herbal, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, weight control, liver care, brain health, eye care, feminine health, and sensual health care. It also provides functional ingredients, microbial fermentation, and food inspection services. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.